We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
-4.3%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$5.81B
AUM Growth
+$135M
Cap. Flow
+$468M
Cap. Flow %
8.05%
Top 10 Hldgs %
22.38%
Holding
604
New
28
Increased
196
Reduced
108
Closed
52

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$52.7M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$45.1M
3
PCAR icon
PACCAR
PCAR
+$42.3M
4
KLAC icon
KLA
KLAC
+$37.4M
5
AMZN icon
Amazon
AMZN
+$23.1M

Top Sells

Rank Stock Value
1
MAR icon
Marriott International
MAR
+$51.7M
2
ABT icon
Abbott
ABT
+$30.9M
3
PFE icon
Pfizer
PFE
+$29.6M
4
VSAT icon
Viasat
VSAT
+$18M
5
QCOM icon
Qualcomm
QCOM
+$14.8M

Sector Composition

Rank Sector Weight
1 Technology 31.85%
2 Healthcare 18.76%
3 Financials 9.65%
4 Consumer Discretionary 9.57%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAR icon
276
Marriott International
MAR
$93.7B
$1.94M 0.03%
9,700
-260,000
-96% -$51.7M
JLL icon
277
Jones Lang LaSalle
JLL
$17B
$1.93M 0.03%
13,777
+148
+1% +$24.2K
TS icon
278
Tenaris
TS
$29.1B
$1.92M 0.03%
60,000
TSM icon
279
TSMC
TSM
$2.15T
$1.89M 0.03%
21,820
-48,380
-69% -$4.57M
HALO icon
280
Halozyme
HALO
$9.89B
$1.87M 0.03%
47,800
SHOP icon
281
Shopify
SHOP
$190B
$1.86M 0.03%
35,000
MPC icon
282
Marathon Petroleum
MPC
$89.1B
$1.85M 0.03%
12,000
BBIO icon
283
BridgeBio Pharma
BBIO
$16.1B
$1.85M 0.03%
68,225
ANET icon
284
Arista Networks
ANET
$252B
$1.84M 0.03%
40,000
MRO
285
DELISTED
Marathon Oil Corporation
MRO
$1.84M 0.03%
66,955
+891
+1% +$23K
ASND icon
286
Ascendis Pharma A/S
ASND
$16.2B
$1.76M 0.03%
18,500
FMC icon
287
FMC
FMC
$1.35B
$1.7M 0.03%
25,787
-27,186
-51% -$2.35M
CTSH icon
288
Cognizant
CTSH
$25B
$1.7M 0.03%
+25,000
New +$1.73M
INFY icon
289
Infosys
INFY
$50.3B
$1.7M 0.03%
100,000
HSY icon
290
Hershey
HSY
$35.8B
$1.68M 0.03%
8,318
-19,669
-70% -$4.4M
EXEL icon
291
Exelixis
EXEL
$14.1B
$1.67M 0.03%
74,500
TRV icon
292
Travelers Companies
TRV
$79.9B
$1.66M 0.03%
9,900
IDXX icon
293
Idexx Laboratories
IDXX
$46.3B
$1.61M 0.03%
3,690
+450
+14% +$224K
KRTX
294
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.61M 0.03%
9,470
+2,400
+34% +$451K
BRK.A icon
295
Berkshire Hathaway Class A
BRK.A
$1.11T
$1.59M 0.03%
3
TGT icon
296
Target
TGT
$67B
$1.56M 0.03%
14,213
-4,110
-22% -$522K
PASG icon
297
Passage Bio
PASG
$15.2M
$1.55M 0.03%
118,040
+10,000
+9% +$164K
NLY icon
298
Annaly Capital Management
NLY
$17B
$1.55M 0.03%
82,800
CBRE icon
299
CBRE Group
CBRE
$43.8B
$1.53M 0.03%
20,900
AFL icon
300
Aflac
AFL
$63.5B
$1.53M 0.03%
19,700

Similar funds

Erste Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Erste Asset Management held 604 positions worth $5.81B, up 2.4% from $5.67B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Erste Asset Management deployed $468M of net new capital in Q3 2023, opening 28 new positions and adding to 196 existing holdings. Its largest new stake was Constellation Brands: 50,120 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Marriott International, an estimated $51.7M trimmed.

  • Erste Asset Management's largest Q3 2023 buy was Constellation Brands: 50,120 shares worth $12.6M.
  • Erste Asset Management added most to Visa in Q3 2023, an estimated $52.7M increase.
  • Erste Asset Management's biggest Q3 2023 reduction was Marriott International, cutting an estimated $51.7M.
  • Erste Asset Management fully exited Viasat in Q3 2023, selling an estimated $18M.
  • Erste Asset Management's ten largest holdings make up 22% of its $5.81B portfolio in Q3 2023.
  • Erste Asset Management opened 28 new positions and closed 52 in Q3 2023.
  • Erste Asset Management's portfolio value rose 2.4% quarter-over-quarter to $5.81B.

Based on Erste Asset Management's 13F filing for Q3 2023, filed 26 Nov 2024.